Mapping the epitopes of the Human Leukocyte Antigen E antibodies 3D12 and 4D12

The commonly used commercially available antibodies 3D12 and 4D12 recognise the human leukocyte antigen E (HLA-E) protein. 3D12 is known to exhibit minimal cross-reactivity with classical HLA-Ia allotypes and we confirm that this is also the case for 4D12. These antibodies bind different epitopes on HLA-E, and differ in their ability to recognise alleles of the major histocompatibility complex E (MHC-E) proteins of rhesus and cynomolgus macaques. Using hybrids of different MHC-E alleles, we have mapped the regions that are critical for the binding of these two antibodies. 3D12 recognises a region on the alpha 3 domain that is unique to HLA-E, on the opposite side to that bound by β2-microglobulin, while 4D12 recognises the start of the alpha 2 domain, adjacent to the C terminus of the presented peptide. Knowledge of the binding sites of these two antibodies will facilitate selection of the best antibody for a given application, and inform interpretation of the resulting data.

• Publication year

  2023

• Venue

  bioRxiv

• Publication date

  2023-07-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1101/2022.05.27.493692
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Antigen presentation by MHC-E: a putative target for vaccination?

  2022cited by this paper
• The SPPL3-Defined Glycosphingolipid Repertoire Orchestrates HLA Class I-Mediated Immune Responses.

  2020cited by this paper
• The unconventional role of HLA-E: The road less traveled.

  2020cited by this paper
• MHC-E–Restricted CD8+ T Cells Target Hepatitis B Virus–Infected Human Hepatocytes

  2020cited by this paper
• Cytomegaloviral determinants of CD8+ T cell programming and RhCMV/SIV vaccine efficacy

  2020cited by this paper
• Detailed and atypical HLA-E peptide binding motifs revealed by a novel peptide exchange binding assay

  2020cited by this paper
• Capturing the antigen landscape: HLA-E, CD1 and MR1.

  2019cited by this paper
• The Role of Glycosphingolipids in Immune Cell Functions

  2019cited by this paper
• Mobilizing unconventional T cells

  2019cited by this paper
• Prevention of tuberculosis in rhesus macaques by a cytomegalovirus-based vaccine

  2018cited by this paper
• The Role of MHC-E in T Cell Immunity Is Conserved among Humans, Rhesus Macaques, and Cynomolgus Macaques

  2018cited by this paper
• Faculty of 1000 evaluation for The Role of MHC-E in T Cell Immunity Is Conserved among Humans, Rhesus Macaques, and Cynomolgus Macaques.

  2018cited by this paper
• Pathogen-derived HLA-E bound epitopes reveal broad primary anchor pocket tolerability and conformationally malleable peptide binding

  2018cited by this paper
• New insights in HLA‐E polymorphism by refined analysis of the full‐length gene

  2017cited by this paper
• Broadly targeted CD8+ T cell responses restricted by major histocompatibility complex E

  2016cited by this paper
• Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition

  2016cited by this paper
• Immune clearance of highly pathogenic SIV infection

  2013cited by this paper
• Cytomegalovirus Vectors Violate CD8+ T Cell Epitope Recognition Paradigms

  2013cited by this paper
• RNA-guided gene activation by CRISPR-Cas9-based transcription factors

  2013cited by this paper
• Enhanced efficiency of human pluripotent stem cell genome editing through replacing TALENs with CRISPRs.

  2013cited by this paper
• Anti-HLA-E mAb 3D12 mimics MEM-E/02 in binding to HLA-B and HLA-C alleles: Web-tools validate the immunogenic epitopes of HLA-E recognized by the antibodies.

  2011cited by this paper
• Reappraisal of the Relationship between the HIV-1-Protective Single-Nucleotide Polymorphism 35 Kilobases Upstream of the HLA-C Gene and Surface HLA-C Expression

  2011cited by this paper
• HLA-E monoclonal antibodies recognize shared peptide sequences on classical HLA class Ia: relevance to human natural HLA antibodies.

  2010cited by this paper
• HLA-E: Strong Association with β2-Microglobulin and Surface Expression in the Absence of HLA Class I Signal Sequence-Derived Peptides1

  2008cited by this paper
• MHC class Ib molecules bridge innate and acquired immunity

  2005cited by this paper
• HLA-E Allelic Variants

  2003cited by this paper
• CORRELATING DIFFERENTIAL EXPRESSION, PEPTIDE AFFINITIES, CRYSTAL STRUCTURES, AND THERMAL STABILITIES*

  2003cited by this paper
• Immune Cell Functions

  2000cited by this paper
• Residue 3 of β2-microglobulin affects binding of class I MHC molecules by the W6/32 antibody

  1999cited by this paper
• TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide.

  1998cited by this paper
• HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences.

  1998cited by this paper
• HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A.

  1998cited by this paper
• The human major histocompatibility complex class Ib molecule HLA‐E binds signal sequence‐derived peptides with primary anchor residues at positions 2 and 9

  1997cited by this paper
• Infection

  1993cited by this paper
• Empty MHC class I molecules come out in the cold

  1990cited by this paper
• A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions.

  1988cited by this paper

• No citing papers are available for this paper.